The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / UHC Announces New Copay Accumulator Policy Affecting In-Office Treatments

UHC Announces New Copay Accumulator Policy Affecting In-Office Treatments

October 6, 2020 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Editor’s note Nov. 23, 2020: As of Nov. 12, 2020, UHC has delayed implementation of the policy discussed below. See “UnitedHealthcare Delays Copay Accumulator Policy.”

You Might Also Like
  • UnitedHealthcare Delays Copay Accumulator Policy
  • ACR Leads Resolution to Address Copay Accumulator Policies at AMA House of Delegates Meeting
  • UnitedHealthcare Delays Policy Changes Affecting Physician-Administered Treatments
Explore This Issue
November 2020
Also By This Author
  • Coding Education at the Annual Meeting

UnitedHealthcare (UHC) announced that, as of Jan. 1, 2021, providers will be required to report the amount their patients receive in copay assistance for office-administered treatments. UHC will then use this information to enforce a copay accumulator, ensuring that no copay assistance funds are applied toward patients’ deductibles or out-of-pocket maximum payments.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR has serious concerns about the impact of this policy on patients’ ability to access treatment. When an accumulator is enforced, copay assistance funds are exhausted in the middle of the plan year and patients are forced to pay out of pocket, or discontinue or switch treatments. The policy also places providers in an ethically objectionable position by requiring they report information that would be used to harm patients.

The ACR strongly opposes this policy and has urged UHC to explore other ways to rein in drug costs without jeopardizing patients’ health. Earlier this week, the ACR led a coalition of 12 provider and patient organizations that sent a letter to UHC advocating against implementation of this policy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We are eager to engage UHC in further dialogue and will continue to push for the policy to be completely rescinded.

If you have questions regarding this policy or other insurance coverage concerns, contact practice@rheumatology.org.

Filed Under: Practice Management Tagged With: Advocacy, copay accumulators, UnitedHealthCare (UHC)Issue: November 2020

You Might Also Like:
  • UnitedHealthcare Delays Copay Accumulator Policy
  • ACR Leads Resolution to Address Copay Accumulator Policies at AMA House of Delegates Meeting
  • UnitedHealthcare Delays Policy Changes Affecting Physician-Administered Treatments
  • UHC Announces New Policy on National Drug Code Requirement

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.